Masakazu Tanaka

11PUBLICATIONS
14CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Molecular targetsHaematologyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 30, 2026
HTLV-1-Infected CD4+ T Cells Drive Spontaneous Lymphoproliferation and Virus-Specific CD8+ Cytotoxic T Lymphocyte Expansion in HAM/TSP.

|Feb 05, 2026
Dimethyl fumarate as a promising therapeutic candidate for virus-associated myelopathy.

Takashi Yoshida, Satoshi Nozuma, Masakazu Tanaka

|Jan 19, 2026
CXCR3/CXCL10 Axis-Mediated T Cell Infiltration in the Lungs of Patients With HTLV-1-Associated Diseases: Implications for Subclinical Pulmonary Involvement.

Kanako Tsuchimoto, Ayasa Mori, Masakazu Tanaka

|Dec 24, 2025
Utility of Tumor Suppressor E2F Target Gene Promoter Elements to Drive Gene Expression Specifically in Cancer Cells.

Kenta Kurayoshi, Masakazu Tanaka, Rinka Nakajima

|Feb 26, 2025
T-Cell Receptor/CD3 Downregulation and Impaired Signaling in HTLV-1-Infected CD4+ T Cells of HAM Patients.

Satoshi Nozuma, Toshio Matsuzaki, Masakazu Tanaka

|Jul 13, 2024
HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load.

Masakazu Tanaka, Norihiro Takenouchi, Shiho Arishima

Pageof 2

Frequent Collaborators

5 joint publications

Daisuke Kodama

5 joint publications

Satoshi Nozuma

4 joint publications

Eiji Matsuura

3 joint publications

Ryuji Kubota